Investors Five-year Losses Continue as Urovo Technology (SZSE:300531) Dips a Further 15% This Week, Earnings Continue to Decline
Investors Five-year Losses Continue as Urovo Technology (SZSE:300531) Dips a Further 15% This Week, Earnings Continue to Decline
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big losses. Zooming in on an example, the Urovo Technology Co., Ltd. (SZSE:300531) share price dropped 52% in the last half decade. We certainly feel for shareholders who bought near the top. And some of the more recent buyers are probably worried, too, with the stock falling 32% in the last year. Shareholders have had an even rougher run lately, with the share price down 27% in the last 90 days.
一般而言,長期投資是必經之路。但這並不意味着長期投資者可以避免巨額損失。舉一個例子,Urovo科技有限公司(深圳證券交易所代碼:300531)的股價在過去五年中下跌了52%。對於在接近頂部買入的股東,我們當然有同感。一些最近的買家可能也感到擔憂,該股去年下跌了32%。股東們最近的表現更加艱難,股價在過去90天中下跌了27%。
Since Urovo Technology has shed CN¥644m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.
由於Urovo Technology在過去7天內已從其價值中減少了6.44億元人民幣,因此讓我們看看長期下跌是否是由該業務的經濟推動的。
To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
用本傑明·格雷厄姆的話來說:從短期來看,市場是一臺投票機器,但從長遠來看,它是一臺稱重機。評估公司情緒變化的一種有缺陷但合理的方法是將每股收益(EPS)與股價進行比較。
During the five years over which the share price declined, Urovo Technology's earnings per share (EPS) dropped by 2.1% each year. Readers should note that the share price has fallen faster than the EPS, at a rate of 14% per year, over the period. This implies that the market is more cautious about the business these days.
在股價下跌的五年中,Urovo Technology的每股收益(EPS)每年下降2.1%。讀者應注意,在此期間,股價的下跌速度快於每股收益,每年下降14%。這意味着如今市場對該業務更加謹慎。
The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).
該公司的每股收益(隨着時間的推移)如下圖所示(點擊查看確切數字)。
It might be well worthwhile taking a look at our free report on Urovo Technology's earnings, revenue and cash flow.
可能值得一看我們關於Urovo Technology收益、收入和現金流的免費報告。
A Different Perspective
不同的視角
We regret to report that Urovo Technology shareholders are down 32% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 13%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 9% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Urovo Technology you should know about.
我們遺憾地報告,Urovo Technology的股東今年下跌了32%(甚至包括股息)。不幸的是,這比整個市場13%的跌幅還要嚴重。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。遺憾的是,去年的業績結束了糟糕的表現,股東在五年內每年面臨9%的總虧損。總的來說,長期股價疲軟可能是一個壞兆頭,儘管逆勢投資者可能希望研究該股以期出現轉機。儘管市場狀況可能對股價產生的不同影響值得考慮,但還有其他因素更爲重要。例如,考慮風險。每家公司都有它們,我們發現了你應該知道的關於Urovo Technology的1個警告標誌。
For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
對於那些喜歡尋找中獎投資的人來說,這份最近有內幕收購的成長型公司的免費名單可能只是門票。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。